Other languages Caplin Point Laboratories Limited NSE India S.E.

Equities

CAPLIPOINT

INE475E01026

Market Closed - NSE India S.E. Other stock markets 07:40:29 2024-07-16 am EDT			5-day change	1st Jan Change
1,534 ^INR	+0.96%		-0.09%	+13.11%

Jun. 11	Caplin Point Laboratories Limited Appoints Thiagaraja Manikandan as Chief Transformation & Digital Officer	CI
May. 24	Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Caplin Point Laboratories Limited Appoints Thiagaraja Manikandan as Chief Transformation & Digital Officer	Jun. 11
Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution	May. 24
Caplin Point Laboratories to Seek Acquisitions	May. 16
Caplin Point Laboratories Limited Declares an Interim Dividend for the Financial Year Ended March 31, 2024	May. 16
Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 16
Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	May. 06
Caplin Point Laboratories Limited Receives Colombia's INVIMA Approval for Its Softgel Capsules Division At Puducherry	May. 06
Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication	Mar. 28
Caplin Steriles Limited, A Subsidiary of Caplin Point Laboratories Limited Gets USFDA Approval for Ketorolac Tromethamine Ophthalmic Solution	Mar. 28
Caplin Point Laboratories Arm Starts Operations of Oncology Facility at Kakkalur, India	Mar. 27
Caplin One Labs Limited, a Wholly Owned Subsidiary of Caplin Point Laboratories Limited Successfully Completes New Oncology (Anti-Cancer) Facility, Commences Operations	Mar. 27
Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09
Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India	Jan. 08
Caplin Point Unit Gets US FDA Final Approval for Generic Ear Infection Drug	Jan. 08
Caplin Point Laboratories Limited Announces Resignation of Hero Velladurai as President, R&D	Dec. 14
Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09
Caplin Point Laboratories Limited Approves Final Dividend for the Year Ended March 31, 2023	23-09-22
Caplin Point Unit's Injectable and Ophthalmic Plant in India Gets VAI Classification from US FDA	23-09-04
Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-07
Caplin Point Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	23-08-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Caplin Point Laboratories Limited NSE India S.E.

Equities

CAPLIPOINT

INE475E01026

Other languages

Filters